JPRN-UMIN000012210
Completed
N/A
Observational study for treatment outcome in patients with HER2-positive metastatic breast cancer who received pertuzumab combination chemotherapy. - Observational study for treatment outcome in patients with HER2-positive metastatic breast cancer who received pertuzumab combination chemotherapy.
ConditionsBreast cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Breast cancer
- Sponsor
- Kurume University Hospital
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Physician judged improper to entry this trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Prospective observational study of the treatment and prognosis in patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.Adult T-cell leukemia-lymphomaJPRN-UMIN000009251JSCT30
Recruiting
N/A
Prospective observational study of the treatment and prognosis in patients with previously untreated indolent B cell lymphomaIndolent B-cell Non-Hodgkin's lymphomaJPRN-UMIN000010175Fukuoka Lymphoma Study Group200
Recruiting
N/A
A prospective study of treatment response of patients with myelofibrosis and PNH type blood cellsmyelofibrosisJPRN-UMIN000045859Juntendo University100
Active, Not Recruiting
N/A
Prospective observational study for Treatment resistance related gene screening using plasma circulating tumor DNA in the third generation EGFR-TKI Osimertinib therapyJPRN-jRCTs031180051Tamiya Akihiro180
Completed
N/A
Prospective observational study on treatment strategy for pancreatic cancer focusing on the chemotherapy responsePancreatic cancerJPRN-UMIN000042331Department of hepato-biliary-pancreatic surgery, Okayama University Graduate School of Medicine76